Global oxidative stress assay market is anticipated to grow at a CAGR of 8.3% during the forecast period (2024-2031). The rising prevalence of chronic diseases such as heart disease, cancer, diabetes, obesity, and hypertension necessitates the use of reliable oxidative stress assays to assess biomarkers. According to Centers for Disease Control and Prevention (.gov), in February 2024, there is an estimated $129.0 million individuals in the US who are affected by at least one major chronic disease, such as heart disease, cancer, diabetes, obesity, or hypertension, as defined by the US Department of Health and Human Services. Furthermore, preventable and treatable chronic diseases are strongly associated with five out of the top ten leading causes of mortality in the country.
Browse the full report description of “Oxidative Stress Assay Market Size, Share & Trends Analysis Report by Product (Instruments, Consumables, and Services), by Test Type (Indirect Assays, Antioxidant Capacity Assays, Enzyme Assays, and Reactive Oxygen Species Assays) by Technology (Enzyme-Linked Immunosorbent Assay (ELISA), Flow Cytometry, Chromatography, Microscopy, and Others) by Disease Type (Cardiovascular Disease, Chronic Obstructive Pulmonary Disease (COPD), Cancer, Respiratory Diseases, Diabetes, and Other) and by End User (Pharmaceutical and Biotechnology Industries, Academic Research institutes, and Clinical Research Organizations) Forecast Period (2024-2031)” at https://www.omrglobal.com/industry-reports/oxidative-stress-assay-market-size
This prevalence has steadily increased over the past two decades and is projected to continue. Additionally, a growing percentage of the population, around 42.0%, are managing two or more chronic conditions, while 12.0% are coping with at least five. The impact of chronic disease extends beyond personal well-being and significantly affects the US healthcare system, with approximately 90.0% of the annual $4.1 trillion healthcare expenditure being devoted to managing and treating chronic diseases and mental health conditions.
The market number available for – 2023-2031
• Base year- 2023
• Forecast period- 2024-2031
• Segment Covered-
o By Product
o By Test Type
o By Technology
o By Disease Type
o By End User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- Abcam Ltd., Cell Biolabs, Inc. Merck KGaA, Promega Corp., Thermo Fisher Scientific Inc. among others.
Key questions addressed by the report.
Global Oxidative Stress Assay Market Report Segment
By Product
By Test Type
By Technology
By Disease Type
By End-User
Global Oxidative Stress Assay Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/oxidative-stress-assay-market-size